Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica N Haladyna

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Epigenomics|May 6, 2015
Epigenetic modifiers in normal and malignant hematopoiesisJessica N Haladyna, Taylor Yamauchi, Tobias Neff, et al.
Experimental Hematology|April 2, 2016
Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapyJessica N Haladyna, Taylor Pastuer, Simone S Riedel, et al.
Leukemia|February 5, 2021
Menin is necessary for long term maintenance of meningioma-1 driven leukemiaClara Libbrecht, Hongbo M Xie, Molly C Kingsley, et al.
Cell Reports|February 25, 2016
Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic LeukemiaEtienne Danis, Taylor Yamauchi, Kristen Echanique, et al.
Science Signaling|October 5, 2017
Inhibition of the oncogenic fusion protein EWS-FLI1 causes G<sub>2</sub>-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcomaStefan K Zöllner, Saravana P Selvanathan, Garrett T Graham, et al.
The Journal of Clinical Investigation|March 2, 2016
MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemiaSimone S Riedel, Jessica N Haladyna, Matthew Bezzant, et al.
Molecular Cancer Therapeutics|April 22, 2017
Mechanisms of Pinometostat (EPZ-5676) Treatment-Emergent Resistance in <i>MLL</i>-Rearranged LeukemiaCarly T Campbell, Jessica N Haladyna, David A Drubin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Epigenomics|May 6, 2015
Epigenetic modifiers in normal and malignant hematopoiesisJessica N Haladyna, Taylor Yamauchi, Tobias Neff, et al.
Experimental Hematology|April 2, 2016
Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapyJessica N Haladyna, Taylor Pastuer, Simone S Riedel, et al.
Leukemia|February 5, 2021
Menin is necessary for long term maintenance of meningioma-1 driven leukemiaClara Libbrecht, Hongbo M Xie, Molly C Kingsley, et al.
Cell Reports|February 25, 2016
Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic LeukemiaEtienne Danis, Taylor Yamauchi, Kristen Echanique, et al.
Science Signaling|October 5, 2017
Inhibition of the oncogenic fusion protein EWS-FLI1 causes G<sub>2</sub>-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcomaStefan K Zöllner, Saravana P Selvanathan, Garrett T Graham, et al.
The Journal of Clinical Investigation|March 2, 2016
MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemiaSimone S Riedel, Jessica N Haladyna, Matthew Bezzant, et al.
Molecular Cancer Therapeutics|April 22, 2017
Mechanisms of Pinometostat (EPZ-5676) Treatment-Emergent Resistance in <i>MLL</i>-Rearranged LeukemiaCarly T Campbell, Jessica N Haladyna, David A Drubin, et al.
Pageof 1